Risk of pneumonia among patients with chronic kidney disease in outpatient and inpatient settings

Medicine (United States)

Volumn 93, Issue 27, 2014, Pages

  Chou, Che Yi ^a,b   Wang, Shu Ming ^a,b   Liang, Chih Chia ^a,b   Chang, Chiz Tzung ^a,b   Liu, Jiung Hsiun ^a,b   Wang, I Kuan ^a,b   Hsiao, Lien Cheng ^a,b   Muo, Chih Hsin ^a   Huang, Chiu Ching ^a,b   Wang, Ruey Yun ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; OUTPATIENT; PNEUMONIA; RISK FACTOR; TAIWAN;

EID: 84919333087     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000174     Document Type: Article

References (23)

1. Guo H, Liu J, Collins AJ, et al. Pneumonia in incident dialysis patients-the United States Renal Data System. Nephrol Dial Transplant. 2008; 23: 680-686.
2. Viasus D, Garcia-Vidal C, Cruzado JM, et al. Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease. Nephrol Dial Transplant. 2011; 26: 2899-2906.
3. Collins AJ, Foley RN, Gilbertson DT, et al. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009; 4(Suppl 1): S5-11.
4. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001; 120: 1883-1887.
5. James MT, Quan H, Tonelli M, et al. CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis. 2009; 54: 24-32.
6. Chung CJ, Huang CY, Tsai HB, et al. Sex differences in the development of malignancies among end-stage renal disease patients: a nationwide population-based follow-up study in Taiwan. PLoS One. 2012; 7: e44675.
7. Liu JH, Lin SY, Hsu CY, et al. The risk for chronic kidney disease in patients with heart diseases: a 7-year follow-up in a cohort study in Taiwan. BMC Nephrol. 2012; 13: 77.
8. Agarwal R, Bunaye Z, Bekele DM, et al. Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease. Am J Nephrol. 2008; 28: 569-575.
9. Hwang SJ, Lin MY, Chen HC, et al. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan. Nephrol Dial Transplant. 2008; 23: 3192-3198.
10. Menendez R, Torres A, Zalacain R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004; 59: 960-965.
11. Slinin Y, Foley RN, Collins AJ. Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Kidney Int. 2006; 70: 1135-1141.
12. Lim WH, Kireta S, Leedham E, et al. Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int. 2007; 72: 1138-1148.
13. Anding K, Gross P, Rost JM, et al. The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant. 2003; 18: 2067-2073.
14. Sester U, Sester M, Hauk M, et al. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant. 2000; 15: 1217-1223.
15. Fernandez-Fresnedo G, Ramos MA, Gonzalez-Pardo MC, et al. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant. 2000; 15: 502-510.
16. Kimmel PL, Phillips TM, Simmens SJ, et al. Immunologic function and survival in hemodialysis patients. Kidney Int. 1998; 54: 236-244.
17. Arnold FW, Ramirez JA, McDonald LC, et al. Hospitalization for community-acquired pneumonia: the pneumonia severity index vs clinical judgment. Chest. 2003; 124: 121-124.
18. Ewig S, Ruiz M, Mensa J, et al. Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med. 1998; 158: 1102-1108.
19. Di Angelantonio E, Chowdhury R, Sarwar N, et al. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ. 2010; 341: c4986.
20. Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA. 2011; 305: 1119-1127.
21. Kent BD, Eltayeb EE, Woodman A, et al. The impact of chronic obstructive pulmonary disease and smoking on mortality and kidney transplantation in end-stage kidney disease. Am J Nephrol. 2012; 36: 287-295.
22. van Gestel YR, Chonchol M, Hoeks SE, et al. Association between chronic obstructive pulmonary disease and chronic kidney disease in vascular surgery patients. Nephrol Dial Transplant. 2009; 24: 2763-2767.
23. Ruiz M, Ewig S, Marcos MA, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med. 1999; 160: 397-405.